Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG

Abstract

MONOCLONAL antibodies can be produced by cultures of permanent cell lines derived by fusion of suitable myelomas with spleen cells from immunised animals1. So far, mainly two mouse myelomas, X63-Ag8 and NSI/1-Ag4.1, have been used for this purpose1,2. When cells from immunised mice are used in the fusion, the mouse × mouse hybrid myelomas can be grown as tumours in appropriate mouse strains. We describe here the preparation and use of a new clone of a rat myeloma, which is suitable for the derivation of rat × rat hybrid myelomas producing specific rat antibodies. The spent medium of hybrid myeloma cultures usually contains 1–20 μg ml−1 antibody. The serum and ascites of the tumour-bearing mice, with few exceptions, yield 1–20 mg ml−1 of antibody, which is 1,000 times more concentrated and very convenient for larger preparations.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Köhler, G. & Milstein, C. Nature 256, 495–497 (1975).

    Article  ADS  Google Scholar 

  2. Köhler, G. & Milstein, C. Eur. J. Immun. 6, 511–519 (1976).

    Article  Google Scholar 

  3. Galfrè, G., Howe, S. C., Milstein, C., Butcher, G. W. & Howard, J. C. Nature 266, 550–552 (1977).

    Article  ADS  Google Scholar 

  4. Springer, T., Galfrè, G., Secher, D. S. & Milstein, C. Eur. J. Immun. 8, 539–551 (1977).

    Article  Google Scholar 

  5. Bazin, H., Deckers, C., Beckers, A. & Heremans, J. F. Int. J. Cancer 10, 568 (1972).

    Article  CAS  Google Scholar 

  6. Cotton, R. G. H. & Milstein, C. Nature 244, 42–43 (1973).

    Article  ADS  CAS  Google Scholar 

  7. Svasti, J. & Milstein, C. Biochem. J. 128, 427–444 (1972).

    Article  CAS  Google Scholar 

  8. Secher, D. S., Milstein, C. & Adetugbo, K. Immun. Rev. 36, 51–72 (1977).

    Article  CAS  Google Scholar 

  9. Milstein, C., Adetugbo, K., Cowan, N. J. & Secher, D. S. Prog. Immun. 2, 157–168 (1974).

    Google Scholar 

  10. Rocca-Serra, J., Milili, M. & Fougereau, M. Eur. J. Biochem. 59, 511–523 (1975).

    Article  CAS  Google Scholar 

  11. Turner, K. J. & Cebra, J. J. Biochemistry 10, 9–17 (1971).

    Article  CAS  Google Scholar 

  12. Fruchter, R. G., Jackson, S. A., Mole, L. E. & Porter, R. R. Biochem. J. 116, 249–259 (1970).

    Article  CAS  Google Scholar 

  13. Edelman, G. M. et al. Proc. natn. Acad. Sci. U.S.A. 63, 78–85 (1969).

    Article  ADS  CAS  Google Scholar 

  14. Poljak, R. J., Amzel, L. M., Chen, B. L., Phizackerley, R. P. & Saul, F. Proc. natn. Acad. Sci. U.S.A. 71, 3440 (1974).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

GALFRÈ, G., MILSTEIN, C. & WRIGHT, B. Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature 277, 131–133 (1979). https://doi.org/10.1038/277131a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/277131a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing